Keros Therapeutics, Inc. <KROS.O>: Wells Fargo cuts target price to $18 from $20
KROS•Related News
Nasdaq trade halt continues <PC.O> reason not available at 03:28 AM
PC•
Nasdaq trade halt continues <MAMK.O> reason not available at 03:28 AM
MAMK•
Berkshire accelerates buybacks, lowers cash stake as profit tops forecasts
BRK.A•
Berkshire Q2 FY26 net earnings more than doubled to $25.67 billion
BRK.A•
Paramount will put 30-film pledge in writing to theater chains
PSKY•